ATE420892T1 - Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg - Google Patents

Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg

Info

Publication number
ATE420892T1
ATE420892T1 AT01985449T AT01985449T ATE420892T1 AT E420892 T1 ATE420892 T1 AT E420892T1 AT 01985449 T AT01985449 T AT 01985449T AT 01985449 T AT01985449 T AT 01985449T AT E420892 T1 ATE420892 T1 AT E420892T1
Authority
AT
Austria
Prior art keywords
proteins
type iii
secreted
secretion
flexneri
Prior art date
Application number
AT01985449T
Other languages
English (en)
Inventor
Agathe Subtil
Claude Parsot
Alice Dautry-Varsat
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE420892T1 publication Critical patent/ATE420892T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01985449T 2000-12-14 2001-12-13 Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg ATE420892T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25511800P 2000-12-14 2000-12-14

Publications (1)

Publication Number Publication Date
ATE420892T1 true ATE420892T1 (de) 2009-01-15

Family

ID=22966904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01985449T ATE420892T1 (de) 2000-12-14 2001-12-13 Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg

Country Status (6)

Country Link
US (2) US20040131624A1 (de)
EP (1) EP1341810B1 (de)
AT (1) ATE420892T1 (de)
AU (1) AU2002234796A1 (de)
DE (1) DE60137449D1 (de)
WO (1) WO2002048185A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1856505A (zh) * 2003-02-24 2006-11-01 巴斯德研究院 分泌型衣原体多肽、其编码多核苷酸及其治疗和诊断用途
WO2005113791A2 (en) * 2004-05-07 2005-12-01 Johnson & Johnson Product Research And Development Methods of identifying modulators of bacterial type iii protein secretion system
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
CA2563214A1 (en) * 2006-10-12 2008-04-12 Institut Pasteur Shigella ipad protein and its use as a potential vaccine against shigella infection
CN110331157B (zh) * 2019-08-02 2021-06-08 湖北大学 一种aep环化酶在大肠杆菌中的融合表达方法、aep环化酶环化能力鉴定方法及其应用
CN110387366B (zh) * 2019-08-02 2021-06-08 湖北大学 一种aep环化酶在毕赤酵母中的表达方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1032674E (pt) * 1997-11-21 2007-03-30 Serono Genetics Inst Sa Sequência genómica e polipéptidos (de chlamydia pneumoniae), seus fragmentos e suas utilizações, em particular para o diagnóstico, prevenção e tratamento de infacção
AU3243199A (en) * 1998-03-05 1999-09-20 University Of British Columbia, The Methods for assaying type iii secretion inhibitors
US6822071B1 (en) * 1998-11-12 2004-11-23 The Regents Of The University Of California Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease

Also Published As

Publication number Publication date
WO2002048185A2 (en) 2002-06-20
WO2002048185A3 (en) 2003-01-03
EP1341810A2 (de) 2003-09-10
US20030045702A1 (en) 2003-03-06
EP1341810B1 (de) 2009-01-14
HK1056369A1 (en) 2004-02-13
US20040131624A1 (en) 2004-07-08
AU2002234796A1 (en) 2002-06-24
DE60137449D1 (de) 2009-03-05

Similar Documents

Publication Publication Date Title
Abrahmsen et al. Analysis of signals for secretion in the staphylococcal protein A gene.
Subtil et al. Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery
Portnoy et al. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity
Döhmer et al. Identification of a type IV secretion substrate of B rucella abortus that participates in the early stages of intracellular survival
Lee et al. Proteomics in gram‐negative bacterial outer membrane vesicles
Kalmokoff et al. Proteomic analysis of Campylobacter jejuni 11168 biofilms reveals a role for the motility complex in biofilm formation
WO2005071088A3 (en) Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
Silver et al. Human Menkes X‐chromosome disease and the staphylococcal cadmium‐resistance ATPase: a remarkable similarity in protein sequences
da Silva Barreira et al. Spontaneous prophage induction contributes to the production of membrane vesicles by the gram-positive bacterium Lacticaseibacillus casei BL23
Habimana et al. Positive role of cell wall anchored proteinase PrtP in adhesion of lactococci
Ott et al. Strain-specific differences in pili formation and the interaction of Corynebacterium diphtheriae with host cells
DK1356060T3 (da) Dobbeltarginintranslokation i Bacillus
Chuzeville et al. Antigen I/II encoded by integrative and conjugative elements of Streptococcus agalactiae and role in biofilm formation
ATE420892T1 (de) Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg
Bassford Jr Export of the periplasmic maltose-binding protein of Escherichia coli
Garrett et al. The role of proteinaceous toxins secreted by Staphylococcus aureus in interbacterial competition
Velaithan et al. Novel synthetic signal peptides for the periplasmic secretion of green fluorescent protein in Escherichia coli
WO2023038961A3 (en) Common cold coronavirus t cell epitopes, methods and uses thereof
US20180201916A1 (en) Variants of the subtilisin carlsberg polypeptide with decreased thermostability
Hsieh et al. Omp52 is a growth-phase-regulated outer membrane protein of Leptospira santarosai serovar Shermani
Brugerolle et al. The rhizoplast of chrysomonads, a basal body–nucleus connector that polarises the dividing spindle
Sousa et al. Antagonistic activity expressed by Shigella sonnei: identification of a putative new bacteriocin
García et al. Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti‐streptococcal vaccine
Saier Jr et al. Bacterial proteins with N-terminal leader sequences resembling mitochondrial targeting sequences of eukaryotes
SG174348A1 (en) Fusion proteins the process to preparation and utilization in expression systems of recombinant proteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties